Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2011,NIDCR,5F31DE019599-03,,Early events in infection of epithelial cells with Epstein-Barr Virus,"VALENCIA, SARAH",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$27,059"
Lymphoma,2011,NCI,5R01CA131354-03,,Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$358,438"
Lymphoma,2011,NCI,5R01CA096856-08,,Novel role of STAT3 in NPM/ALK-induced oncogenesis,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$290,381"
Lymphoma,2011,NCI,5R01CA077429-12,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$419,987"
Lymphoma,2011,NCI,5R01CA129330-03,,Origin of CD5+ B cell Lymphoma/Leukemia in Mice,"HAYAKAWA, KYOKO",INSTITUTE FOR CANCER RESEARCH,PA,"$351,225"
Lymphoma,2011,NCI,5R01CA100603-09,,Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer,"CLEVELAND, JOHN",SCRIPPS RESEARCH INSTITUTE,CA,"$417,344"
Lymphoma,2011,NCI,4R37CA031845-31,,Synthetic Studies Related to Cancer Research/Treatment,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$423,345"
Lymphoma,2011,NCI,5R01CA052004-22,,Control of Gammaherpesvirus Replication,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$310,549"
Lymphoma,2011,NCI,5R01CA138891-02,,In vivo targeting of hematopoetic cells with glycan ligands of siglecs,"PAULSON, JAMES",SCRIPPS RESEARCH INSTITUTE,CA,"$384,203"
Lymphoma,2011,NCI,5R01CA124621-06,,Role of Arsenic Trioxide in Primary Effusion Lymphoma,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$298,566"
Lymphoma,2011,NCI,5R21CA141275-02,,Characterizing Clonogenic Populations in Mantle Cell Lymphoma,"MCCARTY, NAMI",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$189,878"
Lymphoma,2011,NCI,5R01CA139389-02,,Lymphoma Therapy with Reprogrammed Measles Viruses,"CATTANEO, ROBERTO",MAYO CLINIC,MN,"$304,127"
Lymphoma,2011,NIAID,5R01AI065529-05,,Regulatory Networks of Helicobacter pylori,"MERRELL, D",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$367,285"
Lymphoma,2011,NIAID,5R01AI079732-09,,Accessibility Control of Antigen Receptor Gene Assembly,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$372,438"
Lymphoma,2011,NCI,5R01CA116093-05,,Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis,"SIF, SAID",OHIO STATE UNIVERSITY,OH,"$248,805"
Lymphoma,2011,NCI,5R01CA080320-12,,Myc Oncogene Mutations and Polymorphisms in Cancer,"COLE, MICHAEL",DARTMOUTH COLLEGE,NH,"$336,775"
Lymphoma,2011,NCI,5R01CA140806-02,,Proteomic biomarkers of ALK+ lymphoma,"LIM, MEGAN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$310,970"
Lymphoma,2011,NCI,5R37CA042245-26,,Regulation of replication and latency EBV EBNAs,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$356,292"
Lymphoma,2011,NCI,5R01CA136895-03,,Molecular targets in diffuse large B cell lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$251,191"
Lymphoma,2011,NCI,4R37CA076584-14,,F-box proteins: deregulated cell cycle control and proteolysis in cancer,"PAGANO, MICHELE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$446,545"
Lymphoma,2011,NCI,5R01CA031534-27,,MAR Mediated Control of The IgH Enhancer,"TUCKER, PHILIP",UNIVERSITY OF TEXAS AUSTIN,TX,"$249,638"
Lymphoma,2011,NCI,5R01CA137894-03,,EBV Antigen and Cell Cycle Regulation,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$285,308"
Lymphoma,2011,NCI,5R01CA102705-08,,Mismatch repair in V region mutation and isotype switching,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$314,906"
Lymphoma,2011,NCI,5R01CA033192-24,,Transformation by Reticuloendotheliosis Virus,"BOSE, HENRY",UNIVERSITY OF TEXAS AUSTIN,TX,"$292,972"
Lymphoma,2011,NCI,5R01CA078384-13,,E2A as a Tumor Suppressor,"MURRE, CORNELIS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$398,017"
Lymphoma,2011,NCI,5R21CA143785-02,,Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma.,"NEELAPU, SATTVA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$279,772"
Lymphoma,2011,NCI,5R01CA129560-03,,Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas,"HAQUE, AZIZUL",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$296,881"
Lymphoma,2011,NCI,5R21CA141324-02,,Abrogating human CD59 activity for antibody-based cancer therapy,"QIN, XUEBIN",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$214,562"
Lymphoma,2011,NCI,5R01CA066519-17,,EBV-based Strategies for AIDS-related Malignancies,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$261,710"
Lymphoma,2011,NCI,5R00CA126186-05,,Functions of microRNAs in lymphomagenesis,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$239,456"
Lymphoma,2011,NCI,5R01CA102184-06,,Functional Analysis of p53 Polymorphic Variants,"MURPHY, MAUREEN",FOX CHASE CANCER CENTER,PA,"$326,484"
Lymphoma,2011,NCI,5R01CA139319-02,,The ARF Tumor Suppressor,"MURPHY, MAUREEN",FOX CHASE CANCER CENTER,PA,"$351,225"
Lymphoma,2011,NCI,5R01CA122539-04,,Lymphoproliferative Disorders in Primary Immunodeficiencies,"ROUTES, JOHN",MEDICAL COLLEGE OF WISCONSIN,WI,"$282,926"
Lymphoma,2011,NCI,5R01CA132840-03,,Function of REV3L in limiting oncogenesis via DNA damage tolerance,"WOOD, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$309,964"
Lymphoma,2011,NCI,5R01CA076287-13,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$353,533"
Lymphoma,2011,NIAID,5R01AI018757-29,,Host Immunity to EBV Infection in Vitro and in VIvo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$404,291"
Lymphoma,2011,NCI,5R01CA133027-04,,"EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors","SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$291,367"
Lymphoma,2011,NCI,5R01CA070723-15,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$285,015"
Lymphoma,2011,NCI,5R01CA142664-02,,Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.,"YOTNDA, PATRICIA",BAYLOR COLLEGE OF MEDICINE,TX,"$308,958"
Lymphoma,2011,NCI,5R01CA093237-10,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$282,349"
Lymphoma,2011,NCI,5R01CA143032-02,,Molecular Targeting of Diffuse Large B-cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$587,846"
Lymphoma,2011,NCI,5R01CA130752-04,,Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$299,900"
Lymphoma,2011,NCI,5R01CA129682-03,,Regulation of Autophagy and Tumorigenesis by Bif-1,"WANG, HONG-GANG",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$312,178"
Lymphoma,2011,NCI,5R01CA068051-16,,Pathogenesis of EBV Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$454,973"
Lymphoma,2011,NCI,5R01CA124332-05,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$89,923"
Lymphoma,2011,NCI,5R01CA125658-05,,Rac GTPases as Targets in Lymphomagenesis,"ZHENG, YI",CHILDREN'S HOSPITAL MEDICAL CENTER CINCI,OH,"$276,450"
Lymphoma,2011,NCI,5R01CA098495-08,,The Regulation of Somatic Hypermutation,"PAPAVASILIOU, F.",ROCKEFELLER UNIVERSITY,NY,"$266,163"
Lymphoma,2011,NCI,5R01CA073507-14,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$366,175"
Lymphoma,2011,NCI,5R01CA116933-05,,Preventing Tumorigenesis in Developing Lymphocytes,"ZHU, CHENGMING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$283,822"
Lymphoma,2011,NCI,5F32CA132350-03,,Coordinate Suppression of B Cell Lymphoma by PTEN and SHIP,"MILETIC SEDY, ANA",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$54,734"
Lymphoma,2011,NCI,5R01CA117935-05,,p53-Independent Pathways in Mdm2-Mediated Transformation,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$281,892"
Lymphoma,2011,NCI,5R01CA091791-10,,Reactivation of Kaposi's sarcoma-associated herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$273,019"
Lymphoma,2011,NIGMS,1R01GM095606-01,,Coiled-coil Based Drug-Free Macromolecular Therapeutics,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$284,050"
Lymphoma,2011,NCI,5R01CA128941-04,,Regulatory T cells in B cell lymphoma,"LEVITSKY, HYAM",JOHNS HOPKINS UNIVERSITY,MD,"$330,091"
Lymphoma,2011,NCI,5R01CA134451-03,,Computer-assisted Grading and Risk Stratification of Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$272,401"
Lymphoma,2011,NCI,1R01CA155143-01,,Predictors of clinical outcome after therapeutic vaccination in follicular lympho,"NEELAPU, SATTVA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$494,701"
Lymphoma,2011,NCI,5R01CA103642-08,,Immune surveillance in murine gammaherpesvirus infection,"USHERWOOD, EDWARD",DARTMOUTH COLLEGE,NH,"$276,154"
Lymphoma,2011,NCI,5R01CA098285-08,,Towards a Mouse Model of Classical Hodgkin's Disease and PTLD,"RAJEWSKY, KLAUS","IMMUNE DISEASE INSTITUTE, INC.",MA,"$490,125"
Lymphoma,2011,NCI,1R21CA156088-01,,Targeted therapy of pancreatic cancer with in vivo radionuclide generator,"DADACHOVA, EKATERINA",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$180,525"
Lymphoma,2011,NCI,5F32CA139883-02,,The role of miR-155 in cell cycle regulation and tumorigenesis,"SO, ALEX",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$51,326"
Lymphoma,2011,NCI,5R01CA099997-08,,Mechanisms of Alteration of B Lymphocyte Function by LMP1,"BISHOP, GAIL",UNIVERSITY OF IOWA,IA,"$323,724"
Lymphoma,2011,NCI,5R01CA058853-18,,Regulation of EBV Infection in Epithelial Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$284,873"
Lymphoma,2011,NCI,5R37CA012055-39,,Studies of Epstein-Barr Virus,"MILLER, I.",YALE UNIVERSITY,CT,"$446,398"
Lymphoma,2011,NCI,5R01CA089305-10,,MYC's Role in the Initiation and Maintenance of Cancer,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$387,426"
Lymphoma,2011,NCI,5R01CA149707-02,,Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster,"VENTURA, ANDREA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$384,234"
Lymphoma,2011,NCI,5R01CA071540-14,,Molecular Basis of Action of the Putative Oncogene BCL-6,"BARDWELL, VIVIAN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$301,712"
Lymphoma,2011,NIAID,5R01AI023283-26,,Molecular Basis of Immunoglobulin Heavy Chain Switch,"STAVNEZER, JANET",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$454,459"
Lymphoma,2011,NCI,5R01CA104588-07,,RAG-induced DNA damage: mechanisms and responses,"ROTH, DAVID",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$290,271"
Lymphoma,2011,NCI,5R01CA133571-02,,Coordinately regulated alternative splicing in DNA damage and cancer,"CHANDLER, DAWN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$260,853"
Lymphoma,2011,NCI,5R01CA142798-02,,The contribution of protein translation to tumorigenesis,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$382,423"
Lymphoma,2011,NCI,5R01CA138747-02,,microRNA-155 and Lymphoma,"AGUIAR, RICARDO",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$298,894"
Lymphoma,2011,NCI,5R01CA136905-03,,Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$278,653"
Lymphoma,2011,NCI,5R01CA132638-04,,Anti-viral IL6 approach to mitigate KSHV-related disease,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$600,638"
Lymphoma,2011,NCI,2P50CA107399-06A1,,City of Hope Lymphoma SPORE,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$2,185,000"
Lymphoma,2011,NCI,5R01CA131024-03,,The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis,"KRUGER, WARREN",FOX CHASE CANCER CENTER,PA,"$351,225"
Lymphoma,2011,NIBIB,5R01EB002991-08,,Biofunctional Polymers for Intracellular Drug Delivery,"STAYTON, PATRICK",UNIVERSITY OF WASHINGTON,WA,"$507,449"
Lymphoma,2011,NCI,5R01CA129132-04,,Development of cambinol analogues as antilymphoma agents,"BEDALOV, ANTONIO",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$354,244"
Lymphoma,2011,NIAID,5R01AI041769-14,,Cellular Mechanisms of PTLD in Transplant Recipients,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$408,411"
Lymphoma,2011,NCI,5R01CA140754-02,,Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort,"JOHNSON, CHRISTINE C",HENRY FORD HEALTH SYSTEM,MI,"$574,828"
Lymphoma,2011,NHLBI,5R01HL088686-04,,Modeling B cell Lymphoma in the Mouse,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$584,460"
Lymphoma,2011,NCI,5R01CA138636-02,,BETR Therapy for Herpesvirus-Associated Tumors,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$553,505"
Lymphoma,2011,NCI,5R01CA137123-03,,Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle,"TAO, JIANGUO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$268,903"
Lymphoma,2011,NIAID,5R01AI076183-09,,Structural and Functional Studies of gp42 and HLA Class II in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$400,947"
Lymphoma,2011,NIAID,5R01AI068907-04,,"Transcriptional Control of Th-POK, a Key Regulator of Lineage Control","KAPPES, DIETMAR",INSTITUTE FOR CANCER RESEARCH,PA,"$496,340"
Lymphoma,2011,NHLBI,5K08HL091517-04,,Annexin 2 in Lymphoproliferative Angiogenesis,"RUAN, JIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$131,490"
Lymphoma,2011,NIDCR,5R01DE017336-06,,Epigenetic Regulation of Epstein-Barr Virus Latency Programs,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$311,677"
Lymphoma,2011,NCI,5R01CA124311-05,,"Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$247,146"
Lymphoma,2011,NCI,1R01CA148950-01A1,,Regulation of Myc-Mediated Tumorigenesis,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$388,417"
Lymphoma,2011,NIAID,5R01AI077533-03,,Regulation of Immunity and Inflammation by TIPE2,"CHEN, YOUHAI",UNIVERSITY OF PENNSYLVANIA,PA,"$385,914"
Lymphoma,2011,NIAID,5R37AI040227-16,,Biochemistry and Regulation of V(D)J Recombination,"SCHLISSEL, MARK",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$414,829"
Lymphoma,2011,NCI,5R01CA149668-02,,Targeting apoptosis via chemical design of Bcl-2 antagonists,"PELLECCHIA, MAURIZIO",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$384,435"
Lymphoma,2011,NCI,1R01CA156674-01,,A Fourth Outcome: DNA Damage and the Differentiation of B Cells,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$314,884"
Lymphoma,2011,NCI,5R03CA150070-02,,Probiotic Metabolism of Rice Bran Phytochemicals for Chemoprevention,"RYAN, ELIZABETH",COLORADO STATE UNIVERSITY-FORT COLLINS,CO,"$71,295"
Lymphoma,2011,NCI,5R01CA149254-02,,Antibody-CpG conjugates for the treatment of B cell lymphoma,"TIMMERMAN, JOHN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$309,964"
Lymphoma,2011,NIAID,5R41AI087167-02,,Lipid Metabolism and KSHV-associated Lymphoma Pathogenesis,"PARSONS, CHRISTOPHER",APOGEE BIOTECHNOLOGY CORPORATION,PA,"$300,000"
Lymphoma,2011,NCI,1R01CA152923-01A1,,FLT-PET/CT for Therapy Monitoring of DLBCL,"QUON, ANDREW",STANFORD UNIVERSITY,CA,"$672,975"
Lymphoma,2011,NIAID,5R01AI084905-02,,Regulation of B cell development by the proto-oncogene LRF/Pokemon,"MAEDA, TAKAHIRO",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$9,424"
Lymphoma,2011,NCI,5R01CA134051-05,,T Cell Immunity in Endemic Burkitt Lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$450,184"
Lymphoma,2011,NCI,5R01CA093853-09,,The role of p63 and p73 in cancer,"MOLL, UTE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$305,188"
Lymphoma,2011,NCI,5R01CA138268-03,,"Role of the cellular microRNA, miR-155, in EBV type III latency signaling","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$299,900"
Lymphoma,2011,NCI,5R01CA134241-03,,Post-Translational Events Underlying the KSHV vGPCR Pathogenesis,"FENG, PINGHUI",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$316,002"
Lymphoma,2011,NCI,5R01CA127238-05,,Herpesvirus-induced telomerase dysregulation and tumor formation,"JAROSINSKI, KEITH",CORNELL UNIVERSITY ITHACA,NY,"$221,505"
Lymphoma,2011,NCI,5K23CA124465-04,,Novel Biologic Therapies for Hodgkin's Lymphoma,"KASAMON, YVETTE",JOHNS HOPKINS UNIVERSITY,MD,"$140,940"
Lymphoma,2011,NIDCR,5R01DE018304-05,,ART Modulation of Viral Pathogenesis in Oral Epithelia,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$305,055"
Lymphoma,2011,NCI,5T32CA009140-37,,Immunobiology of normal and neoplastic lymphocytes,"PEAR, WARREN",UNIVERSITY OF PENNSYLVANIA,PA,"$666,473"
Lymphoma,2011,NIAID,5R01AI089882-02,,Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep,"WU, HAO",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$376,448"
Lymphoma,2011,NCI,5U10CA013650-39,,Eastern Cooperative Oncology Group,"HABERMANN, THOMAS",MAYO CLINIC,MN,"$211,859"
Lymphoma,2011,NCI,5R01CA122645-04,,Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$308,376"
Lymphoma,2011,NCI,5K08CA140780-02,,Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB,"GEWURZ, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$179,910"
Lymphoma,2011,NIAID,5R03AI085545-02,,A FUNCTIONAL STUDY OF UBIQUITIN C-TERMINAL HYDROLASE L1 EXPRESSION IN B-LYMPHOMA,"SHACKELFORD, JULIA",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$73,260"
Lymphoma,2011,NCI,5R01CA132098-03,,HDAC Inhibitors and CTCL,"SHOWE, LOUISE",WISTAR INSTITUTE,PA,"$396,309"
Lymphoma,2011,NCI,5R01CA096500-10,,Role of KSHV K1 in viral pathogenesis,"DAMANIA, BLOSSOM",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$271,364"
Lymphoma,2011,NCI,2R01CA117830-06,,Regulation of KSHV Latency,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$291,966"
Lymphoma,2011,NCI,1U54CA155496-01,5936,Social Determinants in the Link between Obesity and Cancer,"HOVMAND, PETER",WASHINGTON UNIVERSITY IN ST LOUIS,,"$188,040"
Lymphoma,2011,NCI,5R01CA125195-05,,Molecular Pathways in Suppression and Development of T Lineage Lymphomas,"BASSING, CRAIG",CHILDRENS HOSPITAL OF PHILADELPHIA,PA,"$303,174"
Lymphoma,2011,NIAID,5R01AI087634-02,,The Role of miR-17~92 in Autoimmune Diseases,"XIAO, CHANGCHUN",SCRIPPS RESEARCH INSTITUTE,CA,"$529,821"
Lymphoma,2011,NCI,5R01CA121039-05,,B Cell Lymphoma Therapy,"CHOI, YONG",OCHSNER CLINIC FOUNDATION,LA,"$236,918"
Lymphoma,2011,NHLBI,5R01HL076799-08,,"Inflammatory Proteases, Ubiquitin Proteasome System, and Myocyte Death","SABRI, ABDELKARIM",TEMPLE UNIVERSITY,PA,"$375,000"
Lymphoma,2011,NCI,5R01CA109232-07,,Regulation of the KSHV Latent Promoter,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$234,401"
Lymphoma,2011,NCI,5K07CA140360-02,,"Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma","HUSSAIN, SHEHNAZ",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$125,208"
Lymphoma,2011,NCI,5R01CA135531-04,,Inflammation-regulated microRNA in B cell lymphoma,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$347,704"
Lymphoma,2011,NCI,5R01CA133063-04,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$402,448"
Lymphoma,2011,NIAID,5R01AI081710-02,,Mechanisms of KSHV post-transcriptional gene regulation,"CONRAD, NICHOLAS",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$313,830"
Lymphoma,2011,NCI,5R01CA109335-06,,Significance and Function of HGAL in Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$243,175"
Lymphoma,2011,NIAID,5R01AI076972-05,,Programming of CD8+ T Cell Tolerance by B Cell APC,"SCHOENBERGER, STEPHEN",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$449,155"
Lymphoma,2011,NCI,5R01CA134807-02,,Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas,"SOTOMAYOR, EDUARDO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$455,617"
Lymphoma,2011,NCI,5U10CA047559-21,,Cancer and Leukemia Group B,"SHEA, THOMAS",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$119,336"
Lymphoma,2011,NCI,5R37CA057138-21,,MYC ONCOPROTEIN FUNCTION,"EISENMAN, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$828,348"
Lymphoma,2011,NCI,5R01CA083823-10,,Selective Forces Operative in FeLV Infection,"LEVY, LAURA",TULANE UNIVERSITY OF LOUISIANA,LA,"$231,959"
Lymphoma,2011,NCI,1R01CA158073-01,,The Role of ATM in Suppression of Lymphomas,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,864"
Lymphoma,2011,NCI,5R21CA149978-02,,"Fractionated, Dual-targeted radioimmunotherapy for follicular lymphoma","ELSTROM, REBECCA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$340,155"
Lymphoma,2011,NCI,5R01CA131027-04,,Chimeric T Cell for Therpay of Hodgkin Disease,"SAVOLDO, BARBARA",BAYLOR COLLEGE OF MEDICINE,TX,"$308,958"
Lymphoma,2011,NIAID,5R01AI078267-03,,Transcriptional Control of Hematopoiesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$382,239"
Lymphoma,2011,NCI,5R01CA072649-13,,Somatic Mutation of IG Variable Regions,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$394,809"
Lymphoma,2011,NCI,5R01CA140245-02,,Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction,"PALOMARES, MELANIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$600,681"
Lymphoma,2011,NCI,1U01CA157581-01,,Molecular Diagnosis and Prognosis in Aggressive Lymphoma,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$600,000"
Lymphoma,2011,NCI,1K08CA158069-01,,The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene,"PHILIP, MARY",UNIVERSITY OF WASHINGTON,WA,"$167,400"
Lymphoma,2011,NCI,5R01CA151955-02,,A bifunctional nanomedicine for both specific imaging and targeting therapy of an,"ZU, YOULI",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$309,964"
Lymphoma,2011,NCI,5R01CA101700-07,,1H NMR STUDIES OF NON-HODGKINS LYMPHOMA,"GLICKSON, JERRY",UNIVERSITY OF PENNSYLVANIA,PA,"$343,695"
Lymphoma,2011,NCI,5R01CA147791-02,,K-Rta as a Novel SUMO and Epigenetic Regulator,"IZUMIYA, YOSHIHIRO",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$308,790"
Lymphoma,2011,NIAID,5R01AI063058-07,,Mechanism and regulation of DNA end processing in V(D)J recombination and repair,"SEKIGUCHI, JOANN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$345,409"
Lymphoma,2011,NCI,5R21CA152858-02,,PREDICTING OUTCOME OF EXPERIMENTAL THERAPY IN LYMPHOMAS BY 31P & 1H MRS,"ARIAS-MENDOZA, FERNANDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$169,836"
Lymphoma,2011,NCI,5R01CA127530-04,,The role of protein kinase PKK in BAFF signaling and B-cell malignancies,"ZHAO, JIYONG",UNIVERSITY OF ROCHESTER,NY,"$309,964"
Lymphoma,2011,NCI,5R37CA037295-28,,AIDS Associated Lymphoproliferative Disorders,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$390,425"
Lymphoma,2011,NIAID,5R01AI078980-03,,Motor protein regulation of T cell receptor signaling,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$401,841"
Lymphoma,2011,NIAID,5R01AI072194-03,,ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$464,567"
Lymphoma,2011,NCI,1UH2CA158689-01,,Role of Reactive Oxygen Species in B Lymphoma Fate,"CAREY, GREGORY",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$254,808"
Lymphoma,2011,NCI,5R00CA125994-05,,Combining Computational and Experimentation to Interrogate NF-kappaB Signaling,"COVERT, MARKUS",STANFORD UNIVERSITY,CA,"$241,530"
Lymphoma,2011,NCI,5R01CA139119-02,,A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$260,852"
Lymphoma,2011,NCRR,5R24RR023343-05,,Herpesvirus latency and reactivation in macaque models of human disease,"ROSE, TIMOTHY",SEATTLE CHILDREN'S HOSPITAL,WA,"$603,389"
Lymphoma,2011,NCI,5R01CA083937-09,,Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,"GELINAS, CELINE",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$183,634"
Lymphoma,2011,NCI,5R03CA143947-02,,Energy balance and nutrigenetic analysis of non-Hodgkin lymphoma,"BRACCI, PAIGE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$74,933"
Lymphoma,2011,NCI,5R01CA127433-05,,Signal transduction inhibitor therapy for Lymphoma,"WITZIG, THOMAS",MAYO CLINIC,MN,"$325,779"
Lymphoma,2011,NIDCR,5R01DE018926-05,,Pathogenesis of oral rhesus lymphocryptovirus infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$359,692"
Lymphoma,2011,NCI,5R01CA056764-17,,Activation of BCL-2 in Hematologic Malignancies,"BOXER, LINDA","PALO ALTO INSTITUTE FOR RES & EDU, INC.",CA,"$281,785"
Lymphoma,2011,NCI,5R01CA130867-04,,Identifying genetic mechanisms in T-ALL with an inducible Sleeping Beauty system,"DUPUY, ADAM",UNIVERSITY OF IOWA,IA,"$301,913"
Lymphoma,2011,NCI,1R01CA151748-01A1,,Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$491,503"
Lymphoma,2011,NCI,1R01CA151899-01A1,,Communication Skills Intervention to Promote Transition into Survivorship,"KISSANE, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$623,331"
Lymphoma,2011,NCI,1R01CA149445-01A1,,A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma,"BIRMANN, BRENDA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$617,616"
Lymphoma,2011,NIAID,5R03AI083062-02,,3-D Oral Mucosa Model for EBV Pathogenesis,"STOWE, RAYMOND","MICROGEN, LLC",TX,"$76,725"
Lymphoma,2011,NIBIB,2R01EB001994-12,,Imaging Based Dosimetry for Individualized Internal Emitter Therapy,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$481,328"
Lymphoma,2011,NCI,5R01CA139083-03,,The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma,"RUBENSTEIN, JAMES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$310,117"
Lymphoma,2011,NCI,5R01CA104348-07,,Transcriptional silencing by the BCL6 oncoprotein,"MELNICK, ARI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$258,054"
Lymphoma,2011,NCI,1R01CA151351-01A1,,Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy,"GALARDY, PAUL",MAYO CLINIC,MN,"$327,228"
Lymphoma,2011,NCI,1R01CA154653-01A1,,Molecular epidemiology/functional analysis of microRNAs in Non-Hodgkin's lymphoma,"ZHU, YONG",YALE UNIVERSITY,CT,"$343,413"
Lymphoma,2011,NIBIB,1R01EB012569-01A1,,Multi-functional Nanocarrier against Canine Lymphoma,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$547,918"
Lymphoma,2011,NCI,5R01CA047006-24,,Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$554,148"
Lymphoma,2011,NCI,5R01CA124596-04,,Oncogenes and oncogenic microRNAs in chicken tumors,"BEEMON, KAREN",JOHNS HOPKINS UNIVERSITY,MD,"$324,656"
Lymphoma,2011,NCI,1R01CA151533-01A1,,Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma,"AMIN, HESHAM",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Lymphoma,2011,NCI,1R01CA155226-01A1,,Targeting the heat shock response for the therapy of DLBCL,"MELNICK, ARI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$541,013"
Lymphoma,2011,RMAP,5R03DA031086-02,,A Cell-Based Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,"DAVIS, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$38,315"
Lymphoma,2011,NCI,5R01CA124540-04,,Multiple Roles of the API2 Moiety in API2-MALT1-Mediated Lymphomagenesis,"MCALLISTER-LUCAS, LINDA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$309,532"
Lymphoma,2011,NCI,5R33CA116127-04,,UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY,"COOPER, LAURENCE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$459,850"
Lymphoma,2011,NHLBI,5R01HL094603-02,,Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients,"METES, DIANA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$375,145"
Lymphoma,2011,NCI,5R01CA142809-02,,Signal Transduction Pathways in CD30-positive Lymphomas,"DUCKETT, COLIN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$309,234"
Lymphoma,2011,NCI,5R01CA153248-02,,Enhancing tumor-targeted antibody therapy with a second NK activating antibody.,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$259,878"
Lymphoma,2011,NCI,5R01CA128803-05,,Identifying determinants of chemotherapeutic response in vivo,"HEMANN, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$273,789"
Lymphoma,2011,NIAID,5K25AI079404-04,,Light Weight Modeling of Epstein Barr Virus,"SHAPIRO, MICHAEL",TUFTS UNIVERSITY BOSTON,MA,"$124,632"
Lymphoma,2011,OD,1R21CA152789-01A1,,Eating for Life: Dietary Behaviors Among Long Term Cancer Survivors,"SMITH, KATHERINE",JOHNS HOPKINS UNIVERSITY,MD,"$218,819"
Lymphoma,2011,NCI,1R21CA152564-01A1,,Nanosensor device for the detection of H. Pylori and prevention of gastric cancer,"RIGAS, ANASTASIA","NANOMEDICON, LLC",NY,"$152,250"
Lymphoma,2011,NCI,5R01CA076445-11,,Studies of HHV-8 vIL-6 Function,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$349,564"
Lymphoma,2011,NCI,5R01CA112211-05,,SPONTANEOUS CANINE MODELS FOR CANCER GENE DISCOVERY,"BREEN, MATTHEW",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$273,831"
Lymphoma,2011,NCI,5F31CA150442-02,,EBNA1 Functions Required in Burkitt's Lymphomas and Other Immortalized B-Cells,"WASHINGTON, AMBER",LOUISIANA STATE UNIV HSC NEW ORLEANS,LA,"$29,355"
Lymphoma,2011,NCI,5R01CA152212-02,,Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents,"CHENG, YI-QIANG",UNIVERSITY OF WISCONSIN MILWAUKEE,WI,"$218,127"
Lymphoma,2011,NCI,1F32CA159469-01,,Asymmetric Total Synthesis of Vindoline and Novel Analogues,"SKEPPER, COLIN",SCRIPPS RESEARCH INSTITUTE,CA,"$48,398"
Lymphoma,2011,NIDCR,5R01DE019249-04,,Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$370,916"
Lymphoma,2011,NCI,5R01CA153260-12,,Control of Lineage Commitment in Developing Thymocytes,"KAPPES, DIETMAR",INSTITUTE FOR CANCER RESEARCH,PA,"$439,299"
Lymphoma,2011,NCI,5R01CA092104-08,,Biologic Therapy for B-cell non-Hodgkin's Lymphoma,"ANSELL, STEPHEN",MAYO CLINIC,MN,"$250,979"
Lymphoma,2011,NCI,5K01CA138559-03,,Antibody-mediated Gene Therapy for the Treatment of Cancer,"DANIELS, TRACY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$142,677"
Lymphoma,2011,NCI,5R00CA131474-05,,Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells,"NEILSON, JOEL",BAYLOR COLLEGE OF MEDICINE,TX,"$241,531"
Lymphoma,2011,NCI,5R01CA092153-09,,Molecular Epidemiology of NHL and CLL,"CERHAN, JAMES",MAYO CLINIC,MN,"$584,461"
Lymphoma,2011,NCI,5R01CA137488-17,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$464,573"
Lymphoma,2011,NCI,5R01CA134234-04,,Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$301,385"
Lymphoma,2011,NCI,5R01CA122569-04,,Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma,"ROOK, ALAIN",UNIVERSITY OF PENNSYLVANIA,PA,"$259,920"
Lymphoma,2011,NHLBI,5F30HL103193-02,,Adoptive cell therapy for lymphoma: A study on the role of CD4 memory T cells in,"GOLDSTEIN, MATTHEW",STANFORD UNIVERSITY,CA,"$31,130"
Lymphoma,2011,NIA,5F30AG035484-03,,Role of dre-1/FBXO11 in apoptosis,"CHIORAZZI, MICHAEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$46,800"
Lymphoma,2011,NCI,1R43CA153474-01A1,,Virus-Targeted Therapy for Malignancies,"PERRINE, SUSAN","PHOENICIA BIOSCIENCES, INC.",MA,"$288,895"
Lymphoma,2011,FIC,5D43CA153707-02,,Developing Research Capacity for AIDS Malignancy in Kenya,"REMICK, SCOT",WEST VIRGINIA UNIVERSITY,WV,"$37,500"
Lymphoma,2011,NCI,5D43CA153707-02,,Developing Research Capacity for AIDS Malignancy in Kenya,"REMICK, SCOT",WEST VIRGINIA UNIVERSITY,WV,"$499,475"
Lymphoma,2011,NCI,5K08CA133521-03,,Role of B-cell oncogenes and microRNA-34 in B-lymphopoiesis and neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$158,893"
Lymphoma,2011,NCI,1R43CA159843-01,,A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma,"BALHORN, RODNEY","SHAL TECHNOLOGIES, INC.",CA,"$149,959"
Lymphoma,2011,NIAID,1F32AI093076-01A1,,The role of Bcl6 in the differentiation and function of Tfh,"KROENKE, MARK",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$17,061"
Lymphoma,2011,NIAAA,5R01AA017972-03,,Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,"GARTENHAUS, RONALD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$339,003"
Lymphoma,2011,NCI,5R01CA095318-07,,Role of B Cells in Murine Gammaherpesvirus-68 Latency,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$330,795"
Lymphoma,2011,NCI,1R13CA159723-01,,"1st International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymp","METZGER, MONIKA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$5,000"
Lymphoma,2011,NCI,5K08CA140718-03,,Regulation and Dysregulation of Antibody Diversification,"STROUT, MATTHEW",YALE UNIVERSITY,CT,"$174,420"
Lymphoma,2011,NCI,1R13CA159842-01,,Beyond GWAS: the next 10 years of InterLymph,"COZEN, WENDY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$10,000"
Lymphoma,2011,NIEHS,1R13CA159842-01,,Beyond GWAS: the next 10 years of InterLymph,"COZEN, WENDY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$2,000"
Lymphoma,2011,NCI,2R01CA090571-10,,"CRTC2 in Cellular Development, Function, and Neoplasia","TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$273,031"
Lymphoma,2011,NCI,5F32CA139868-03,,Development of a Pd Catalyzed 3+2 Annulation and Synthesis of Daphnicyclidin B,"MANNING, JAMES",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$53,042"
Lymphoma,2011,NCI,2P01CA044991-23A1,8453,Radioimmunotherapy for Lymphoma,"GOPAL, AJAY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$275,955"
Lymphoma,2011,NCI,2P01CA044991-23A1,8454,Pretargeted Radioimmunotherapy for Hematologic Malignancies,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$324,833"
Lymphoma,2011,NCI,2P01CA044991-23A1,8455,Administrative and Statistical Core,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$455,374"
Lymphoma,2011,NCI,2P01CA044991-23A1,8456,Nuclear Medicine Core,"RAJENDRAN, JOSEPH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$631,694"
Lymphoma,2011,NCI,2P01CA044991-23A1,8457,Biologics Production Core,"BALDWIN, JANELL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$143,546"
Lymphoma,2011,NCI,5K23CA140722-02,,Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma,"FAN, ALICE",STANFORD UNIVERSITY,CA,"$173,448"
Lymphoma,2011,NCI,5R01CA116481-05,,The Role of Fbxw7 in genetic instability and cancer,"MAO, JIAN-HUA",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$345,303"
Lymphoma,2011,NCI,5R01CA108609-08,,Anti-viral DC/NK interactions,"MUNZ, CHRISTIAN",UNIVERSITY OF ZURICH,SWITZE,"$176,961"
Lymphoma,2011,NCI,5R01CA130826-04,,Software & Hardware Inference Engines for Automated Determination of Primary Cell,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,616,284"
Lymphoma,2011,NCI,5K01CA122192-05,,Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,"PEDERSEN, IRENE",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$137,220"
Lymphoma,2011,NIAID,5R01AI085024-03,,Gene and Cytokine Expression in Tolerance and GVHD,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$392,040"
Lymphoma,2011,FIC,5D43CA153715-02,,Columbia-South Africa Training Program for Research on HIV-associated Malignanci,"NEUGUT, ALFRED",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$37,500"
Lymphoma,2011,NCI,5D43CA153715-02,,Columbia-South Africa Training Program for Research on HIV-associated Malignanci,"NEUGUT, ALFRED",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$491,712"
Lymphoma,2011,NCI,5K08CA127353-04,,Epigenetic Mechanisms of Lymphomagenesis.,"SHAKNOVICH, RITA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$138,672"
Lymphoma,2011,NCI,5K24CA128953-04,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$171,205"
Lymphoma,2011,NCI,5K08CA143151-02,,Role of Sonic Hedgehog Signaling Pathway in Diffuse Large B-Cell Lymphoma,"VEGA-VAZQUEZ, FRANCISCO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$170,640"
Lymphoma,2011,NCI,2R01CA088763-10A1,,LANA and Cellular Gene Expression,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$230,935"
Lymphoma,2011,NIDCR,1P01DE021954-01,5226,Cell Core,"BARCY, SERGE",SEATTLE CHILDREN'S HOSPITAL,WA,"$182,906"
Lymphoma,2011,NCI,5R01CA102667-07,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$284,657"
Lymphoma,2011,NIAID,5R01AI078234-03,,New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome,"MIKOVITS, JUDY",WHITTEMORE PETERSON INSTITUTE,NV,"$302,866"
Lymphoma,2011,NCI,1R01CA154228-01A1,,Targeting vFLIP for the treatment of KSHV-associated malignancies,"CESARMAN, ETHEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$350,675"
Lymphoma,2011,NCI,5R03CA150037-02,,"Non-Hodgkin lymphoma in women: reproductive, hormonal and genetic factors","BRACCI, PAIGE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$74,933"
Lymphoma,2011,NCI,5R01CA129962-04,,Heat shock protein 90 antagonist-based therapy of mantle cell lymphoma,"BHALLA, KAPIL",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$301,913"
Lymphoma,2011,NCI,5K99CA151827-02,,ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS,"DOMINGUEZ-SOLA, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$144,645"
Lymphoma,2011,RMAP,5R01ES020116-02,,Epigenomic profiling of histone turnover kinetics in mammalian cells,"HENIKOFF, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$481,299"
Lymphoma,2011,NCI,1R01CA160556-01,,Escape from gammaherpesvirus-induced mRNA destruction,"GLAUNSINGER, BRITT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$305,527"
Lymphoma,2011,NCI,5K08CA148821-02,,The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma,"DAVILA, MARCO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$168,661"
Lymphoma,2011,NCI,5R43CA153811-02,,Rare Protein Detection on Cell Surfaces: Ultrasensitive Detection of B-Cell Chron,"KOHNE, DAVID","JADEN BIOSCIENCE, INC.",CA,"$157,179"
Lymphoma,2011,NCI,5R44CA141754-03,,Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy,"ROSSI, EDMUND","IMMUNOMEDICS, INC.",NJ,"$2,283,892"
Lymphoma,2011,NCI,5R01CA156690-02,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$316,215"
Lymphoma,2011,RMAP,5R01CA156690-02,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$322,733"
Lymphoma,2011,NCI,2P01CA087497-11,,Roles and regulation of p53,"PRIVES, CAROL",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$1,812,196"
Lymphoma,2011,NCI,1R01CA160300-01,,Cellular Response to Short Telomeres in B-Cell Lymphoma,"GREIDER, CAROL",JOHNS HOPKINS UNIVERSITY,MD,"$537,001"
Lymphoma,2011,NCI,2R01CA115284-06A1,,KSHV RTA: more than viral replication,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$303,371"
Lymphoma,2011,NCI,1R01CA161026-01,,Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$449,734"
Lymphoma,2011,NCI,1K05CA160724-01,,Survivorship: Mentoring and Bridging Primary Care and Oncology,"OEFFINGER, KEVIN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$164,278"
Lymphoma,2011,NCI,2P01CA019014-32A1,6231,DNA-Protein Interactions in Herpes Viruses,"GRIFFITH, JACK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$270,533"
Lymphoma,2011,NCI,2P01CA019014-32A1,6234,Cellular Reprogramming by KSHV Latent Genes and miRNAs,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$291,273"
Lymphoma,2011,NCI,2P01CA019014-32A1,6235,Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2),"RAAB-TRAUB, NANCY",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$291,372"
Lymphoma,2011,NHLBI,1U10HL109322-01,,The Ohio State Blood and Marrow Transplant Reseach Consortium,"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$176,467"
Lymphoma,2011,NHLBI,2U10HL069233-11,,Nebraska/Kansas Blood and Marrow Transplant Research Network,"VOSE, JULIE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$158,535"
Lymphoma,2011,NCI,1R01CA154643-01A1,,Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$633,902"
Lymphoma,2011,NCI,1R01CA140337-01A2,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$325,775"
Lymphoma,2011,NCI,1R21CA161889-01,,A Phase I trial combining fenretinide and safingol to target overproduction of di,"MAURER, BARRY",TEXAS TECH UNIVERSITY HEALTH SCIS CENTER,TX,"$323,700"
Lymphoma,2011,NCI,1R21CA162002-01,,EBV Specific T-cells from 3rd party donors for treatment of EBV-associated malign,"O'REILLY, RICHARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$375,713"
Lymphoma,2011,NCI,1R21CA156222-01A1,,"Phase 1 of AR-42 in relapsed CLL, lymphoma, myeloma","HOFMEISTER, CRAIG",OHIO STATE UNIVERSITY,OH,"$287,761"
Lymphoma,2011,NCI,1K08CA151450-01A1,,Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma,"LABELLE, JAMES",DANA-FARBER CANCER INSTITUTE,MA,"$170,100"
Lymphoma,2011,NCI,1R21CA156168-01A1,,Exome-wide screening for common mutations in lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$202,754"
Lymphoma,2011,NCI,1R03CA156357-01A1,,Risk of Non-Hodgkin's Lymphoma in Relation to Tricyclic Antidepressant Use,"CHUBAK, JESSICA",GROUP HEALTH COOPERATIVE,WA,"$80,000"
Lymphoma,2011,NCI,4R01CA137198-03,,Monoclonal Antibody-Induced NK Cell Activation and Complement,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$241,530"
Lymphoma,2011,NCI,4R01CA136907-03,,Targeting the proteasome to overcome therapy resistance in B-NHL,"CZUCZMAN, MYRON",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$354,594"
Lymphoma,2011,NCI,4R01CA076379-13,,"Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma","CLEVELAND, JOHN",SCRIPPS FLORIDA,FL,"$363,164"
Lymphoma,2011,NCI,4R01CA104682-07,,Genetic Susceptibility to non-Hodgkin Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$270,807"
Lymphoma,2011,NCI,5F31CA150523-02,,Role of HIV-1 Tat in the activation of HERV-K and development of HIV-1-lymphoma,"GONZALEZ-HERNANDEZ, MARTA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$33,124"
Lymphoma,2011,NCI,1R21CA162277-01,,Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma,"WEBB, TONYA",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$195,750"
Lymphoma,2011,NCI,1R43CA162582-01,,Reducing Complement Inhibition to Treat Leukemia and Lymphoma,"CARTER, DARRICK","COMPLIMENT, INC.",WA,"$300,000"
Lymphoma,2011,NCI,1R13CA162876-01,,14th International Workshop on Kaposi's Sarcoma-Associated Herpesvirus and Relate,"KEDES, DEAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$2,000"
Lymphoma,2011,NCI,1R01CA162964-01,,Antibody-interferon fusion proteins for treatment of B-cell malignancies,"MORRISON, SHERIE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2011,NCI,5P01CA013106-40,0007,Regulation of Pre-mRNA Splicing in Tumorigenesis,"KRAINER, ADRIAN",COLD SPRING HARBOR LABORATORY,NY,"$595,451"
Lymphoma,2011,NCI,5P01CA013106-40,0027,microRNAs in Human Cancer,"HANNON, GREGORY",COLD SPRING HARBOR LABORATORY,NY,"$631,506"
Lymphoma,2011,NCI,5P01CA013106-40,0028,Tumor Suppression,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$674,249"
Lymphoma,2011,NCI,5P30CA033572-28,9023,Developmental Funds,"KRONTIRIS, THEODORE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$318,042"
Lymphoma,2011,NIDCR,5R01DE019811-02,,Cell Penetrating Helical Peptide Inhibitors of vFLIP K13,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$381,065"
Lymphoma,2011,NCI,1R01CA163217-01,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$305,754"
Lymphoma,2011,NCI,5P01CA094237-09,0001,OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$271,819"
Lymphoma,2011,NCI,5P01CA094237-09,0002,THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY,"WANG, RONGFU",BAYLOR COLLEGE OF MEDICINE,TX,"$269,219"
Lymphoma,2011,NCI,3R01CA116933-05S1,,Preventing Tumorigenesis in Developing Lymphocytes,"ZHU, CHENGMING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$110,294"
Lymphoma,2011,NCI,5P50CA094056-11,0003,Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$258,043"
Lymphoma,2011,NCI,5U54CA112967-07,6516,Migration Networks,"GERTLER, FRANK",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$382,025"
Lymphoma,2011,NCI,5U54CA112967-07,6518,DNA Damage Networks,"YAFFE, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$318,057"
Lymphoma,2011,NCI,5P01CA078902-13,8825,Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$184,831"
Lymphoma,2011,NCI,5U54CA149145-02,6610,Center,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$1,249,074"
Lymphoma,2011,NCI,5U54CA149145-02,6611,COMPUTATIONAL ANALYSIS OF DIFFERENTIATION IN CANCER PROGRESSION,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$444,971"
Lymphoma,2011,NCI,5U54CA149145-02,6613,MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMA,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$194,598"
Lymphoma,2011,NCI,5U54CA149145-02,6614,MODELING THE ROLE OF DIFFERENTIATION IN T-ALL,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$171,867"
Lymphoma,2011,NCI,261200800001E-38-0-69,,Tumor Molecular Sequencing: Cancer Genomics Database,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$1,900,000"
Lymphoma,2011,NCI,5P01CA109901-07,7134,Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$687,030"
Lymphoma,2011,NCI,5P01CA109901-07,7135,Molecular Pathways in T Cell Development and T-ALL,"VON BOEHMER, HARALD",DANA-FARBER CANCER INSTITUTE,MA,"$205,122"
Lymphoma,2011,NCI,5P01CA109901-07,7136,The Molecular Function of D-cyclins in T-ALL,"SICINSKI, PETER",DANA-FARBER CANCER INSTITUTE,MA,"$205,596"
Lymphoma,2011,NCI,5P01CA109901-07,7137,Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma,"ALT, FREDERICK","IMMUNE DISEASE INSTITUTE, INC.",MA,"$433,636"
Lymphoma,2011,NCI,5P01CA109901-07,7139,Administrative Core,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$51,594"
Lymphoma,2011,NCI,5P01CA109901-07,7140,Biostatistics and Bioinformatics Core,"NEUBERG, DONNA",DANA-FARBER CANCER INSTITUTE,MA,"$44,011"
Lymphoma,2011,NCI,3R01CA133063-04S1,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$79,631"
Lymphoma,2011,NCI,5P01CA022443-34,0010,Inhibiting The Survival And Proliferation Of EBV-Associated Tumor Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$358,724"
Lymphoma,2011,NCI,5P01CA022443-34,0012,Plasmid Replicons of Human Tumor Viruses,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$354,837"
Lymphoma,2011,NCI,5P01CA022443-34,0013,Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio,"MERTZ, JANET",UNIVERSITY OF WISCONSIN MADISON,WI,"$310,628"
Lymphoma,2011,NIEHS,5P42ES016465-03,6111,Project 2: Cross-Species Comparison of Transplacental Dosimetry PAHs,"CORLEY, RICHARD",OREGON STATE UNIVERSITY,OR,"$351,237"
Lymphoma,2011,NCI,1F31CA165825-01,,Oncogenic cooperation restrained by a putative internal antagonist in miR-17-92,"SABIO, ERICH",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$34,791"
Lymphoma,2011,NCI,5P01CA015396-36,0020,Hodgkin's Lymphoma Stem Cells,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$375,115"
Lymphoma,2011,NCI,5P01CA049605-23,0001,Allografting for Lukemia,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$266,530"
Lymphoma,2011,NCI,5P01CA049605-23,0002,Autografting for Lymphoma,"HORNING, SANDRA",STANFORD UNIVERSITY,CA,"$351,664"
Lymphoma,2011,NCI,5P01CA049605-23,0010,Non-Myeloablative Host Conditioning that Protects Against GVHD,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$314,384"
Lymphoma,2011,NCI,5P01CA049605-23,0014,Control of GVHD with Retained GVT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$273,889"
Lymphoma,2011,NCI,5P01CA049605-23,0015,Transplantation of Purified Hematopoietic Cell Populations Acroos Allogenic Barie,"SHIZURU, JUDITH",STANFORD UNIVERSITY,CA,"$285,652"
Lymphoma,2011,NCI,5P01CA049605-23,0017,Improving Immune Reconstitution via Cytokine-Mediated Expansion of Transplanted,"WEINBERG, KENNETH",STANFORD UNIVERSITY,CA,"$305,158"
Lymphoma,2011,NCI,5P01CA049605-23,0018,Protective Immunity Against Herpesvirus Infections,"ARVIN, ANN",STANFORD UNIVERSITY,CA,"$243,107"
Lymphoma,2011,NCI,5P01CA049605-23,9001,Biostatistics and Data Management Core,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$414,816"
Lymphoma,2011,NCI,5P01CA049605-23,9002,Cellular Imaging and Molecular Pathology,"CONTAG, CHRISTOPHER",STANFORD UNIVERSITY,CA,"$323,974"
Lymphoma,2011,NCI,5P01CA049605-23,9003,Cell Processing and Sample Distribution,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$432,770"
Lymphoma,2011,NCI,4R42CA144104-02,,Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients,"OLSON, JAMES","PRESAGE BIOSCIENCES, INC.",WA,"$544,375"
Lymphoma,2011,NIDCR,5P01DE019085-04,0004,Non-Human Primate Model for KSHV Persistent Infection,"JUNG, JAE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$337,934"
Lymphoma,2011,NCI,5P30CA013696-38,0009,LYMPHOID DVLP AND MALIGNANCIES (LDM),"O'CONNOR, OWEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$33,684"
Lymphoma,2011,NIAID,3R01AI081710-02S1,,Mechanisms of KSHV post-transcriptional gene regulation,"CONRAD, NICHOLAS",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$47,700"
Lymphoma,2011,NCI,5P30CA124435-05,6484,Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$15,416"
Lymphoma,2011,NCI,5P30CA124435-05,6543,Hematopoetic,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$15,417"
Lymphoma,2011,NCI,5P01CA090890-07,6522,Transplacental Chemoprevention of Lung Tumors and Lymphomas,"WILLIAMS, DAVID",OREGON STATE UNIVERSITY,OR,"$287,188"
Lymphoma,2011,NIAID,2R56AI067968-06,,Role and mechanism of action of gamma herpesvirus microRNAs,"CULLEN, BRYAN",DUKE UNIVERSITY,NC,"$392,500"
Lymphoma,2011,NCI,5P30CA013330-39,9032,IMMUNO-ONCOLOGY,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$33,557"
Lymphoma,2011,NCI,5P30CA125123-05,6427,PROGRAM LEADERS,"OSBORNE, C",BAYLOR COLLEGE OF MEDICINE,TX,"$50,047"
Lymphoma,2011,NCI,5P30CA125123-05,6486,HUMAN TISSUE ACQUISITION AND PATHOLOGY,"AYALA, GUSTAVO",BAYLOR COLLEGE OF MEDICINE,TX,"$140,136"
Lymphoma,2011,NCI,5P30CA125123-05,6609,Program leaders---cell and gene therapy,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$15,839"
Lymphoma,2011,NIAID,5P01AI076210-03,8138,Role of SAP (SH2D1A) gene in T cell-dependent antibody response,"TERHORST, CORNELIS",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$292,369"
Lymphoma,2011,NIAID,5P01AI076210-03,8139,Role of TACI mutations in CVID,"GEHA, RAIF",CHILDREN'S HOSPITAL BOSTON,MA,"$477,578"
Lymphoma,2011,NCI,5P01CA100730-09,0005,Role of Inflammation in Tax-mediated Tumorigenesis,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$403,821"
Lymphoma,2011,NCI,5P01CA100730-09,0006,Role of Bone Microenvironment in Tax Induced Malignancies,"WEILBAECHER, KATHERINE",WASHINGTON UNIVERSITY,MO,"$354,977"
Lymphoma,2011,NCI,5P50CA097274-10,0001,P1 - A Novel Approach to the Immunotherapy of B Cell Malignancy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$211,618"
Lymphoma,2011,NCI,5P50CA097274-10,0002,P2 - Signal Transduction Inhibitor Therapy for Lymphoma,"WITZIG, THOMAS",UNIVERSITY OF IOWA,IA,"$281,849"
Lymphoma,2011,NCI,5P50CA097274-10,0003,P3 - Biology and Epidemiology of APRIL and Blys in B-cell and NHL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$396,798"
Lymphoma,2011,NCI,5P50CA097274-10,0004,P4 - Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$261,777"
Lymphoma,2011,NCI,5P50CA097274-10,0005,Developmental Research Program,"RATLIFF, TIMOTHY",UNIVERSITY OF IOWA,IA,"$164,019"
Lymphoma,2011,NCI,5P50CA097274-10,0006,Career Development Program,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$89,597"
Lymphoma,2011,NCI,5P50CA097274-10,9001,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$258,788"
Lymphoma,2011,NCI,5P50CA097274-10,9002,Biostatistics and Bioinformatics,"GEYER, SUSAN",UNIVERSITY OF IOWA,IA,"$161,789"
Lymphoma,2011,NCI,5P50CA097274-10,9003,C4 - Clinical Research,"HABERMANN, THOMAS",UNIVERSITY OF IOWA,IA,"$313,119"
Lymphoma,2011,NCI,5P01CA016038-38,7648,Biology of the Epstein-Barr Virus R Transactivator in Human B Cells,"MILLER, I.",YALE UNIVERSITY,CT,"$406,742"
Lymphoma,2011,NCI,5P01CA016038-38,7650,"Viral RNPs, mRNA Stability and Export","STEITZ, JOAN",YALE UNIVERSITY,CT,"$187,825"
Lymphoma,2011,NCI,7R01CA124332-06,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$200,016"
Lymphoma,2011,NIAID,1R56AI083304-01A1,,The Control of T Cell Development in Responses by PTEN,"TURKA, LAURENCE",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$350,000"
Lymphoma,2011,NCI,5P30CA016359-33,0003,Research Programs-Immunology and Immunotherapy,"MELLMAN, IRA",YALE UNIVERSITY,CT,"$29,137"
Lymphoma,2011,OD,5P30CA016359-33,0003,Research Programs-Immunology and Immunotherapy,"MELLMAN, IRA",YALE UNIVERSITY,CT,$318
Lymphoma,2011,NIAID,1R56AI091748-01A1,,Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination,"SWANSON, PATRICK",CREIGHTON UNIVERSITY,NE,"$361,250"
Lymphoma,2011,NCI,5P50CA130805-04,0001,P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas,"MAHADEVAN, DARUKA",UNIVERSITY OF ARIZONA,AZ,"$269,398"
Lymphoma,2011,NCI,5P50CA130805-04,0002,Project 2: Optimizing Redox Modulation as a Therapeutic Strategy for NHL,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$208,731"
Lymphoma,2011,NCI,5P50CA130805-04,0003,P-3:  Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL),"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$317,399"
Lymphoma,2011,NCI,5P50CA130805-04,0004,P-4: Characterization of Lymphoma-Initiating Cells,"JORDAN, CRAIG",UNIVERSITY OF ROCHESTER,NY,"$199,855"
Lymphoma,2011,NCI,5P50CA130805-04,0005,Developmental Research Program,"LAND, HARTMUT",UNIVERSITY OF ROCHESTER,NY,"$55,755"
Lymphoma,2011,NCI,5P50CA130805-04,0006,Career Development Program,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$73,685"
Lymphoma,2011,NCI,5P50CA130805-04,9001,CB: Tissue Core,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$306,944"
Lymphoma,2011,NCI,5P50CA130805-04,9002,CC: Clinical Trials Core,"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$369,842"
Lymphoma,2011,NCI,5P50CA130805-04,9003,CD: Biostatistics Core,"PETERSON, DERICK",UNIVERSITY OF ROCHESTER,NY,"$147,408"
Lymphoma,2011,NCI,5P50CA130805-04,9004,CA: Administration Core,"FISHER, RICHARD",UNIVERSITY OF ROCHESTER,NY,"$235,983"
Lymphoma,2011,NCI,5P50CA100707-09,0009,P-5: Molecular markers of plasma cell neoplasm evolution,"FONSECA, RAFAEL",MAYO CLINIC ARIZONA,AZ,"$242,099"
Lymphoma,2011,NCI,5P01CA128115-03,7661,Host Defense Regulation by HTLV-1,"ROSENBLATT, JOSEPH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$245,058"
Lymphoma,2011,NCI,3P01CA092625-10S1,,PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$75,000"
Lymphoma,2011,NCI,5P50CA136411-03,5412,Epigenetic-based therapy of Hodgkin lymphoma,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$65,809"
Lymphoma,2011,NCI,5P50CA136411-03,5414,Development of 8-chloro-adenosine therapy,"GANDHI, VARSHA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$65,982"
Lymphoma,2011,NCI,5P50CA136411-03,5415,Non-genotoxic p53 activation as novel therapeutic concept for lymphoma,"ANDREEFF, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$64,753"
Lymphoma,2011,NCI,5P50CA136411-03,5416,Gene expression profiling and pathway targeted therapy in peripheral T-cell,"CHAN, WING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$98,078"
Lymphoma,2011,NCI,5P50CA136411-03,5417,Administrative Core,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$45,412"
Lymphoma,2011,NCI,5P50CA136411-03,5419,Biospecimen Core,"MEDEIROS, L",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$45,414"
Lymphoma,2011,NCI,5P50CA136411-03,5421,Clinical Research Core,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$45,386"
Lymphoma,2011,NCI,5P50CA136411-03,5425,Biostatistics and Bioinformatics Core,"BERRY, DONALD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$44,166"
Lymphoma,2011,NCI,5U54CA143874-03,5002,Deconvoluting Ras Signaling Networks in T Cell Lymphoma,"CHAKRABORTY, ARUP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$433,711"
Lymphoma,2011,NIEHS,3U54ES016115-04S2,,Biological Response Indicators of Environment Stress Centers,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$150,000"
Lymphoma,2011,NIAID,2P01AI061093-08,7981,Investigating Blocks to B Cell Memory in CVID,"CUNNINGHAM-RUNDLES, CHARLOTTE",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$319,822"
Lymphoma,2011,NCI,5P01CA095426-10,0005,INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$483,061"
Lymphoma,2011,NCI,5P01CA095426-10,9003,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$245,001"
Lymphoma,2011,NIAID,7R01AI084905-03,,Regulation of B cell development by the proto-oncogene LRF/Pokemon,"MAEDA, TAKAHIRO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$401,426"
Lymphoma,2011,NCI,5U54CA143907-03,8456,Dynamic State Space Modeling of Cancer Cell Response to Therapy,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,160,630"
Lymphoma,2011,NCI,5U54CA143907-03,8458,Multi-Scale Cancer Modeling: From Cell Phenotypes to Cancer Spread and Response,"CRISTINI, VITTORIO",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$363,394"
Lymphoma,2011,NCI,5P50CA128346-04,0004,Developmental Projects,"MATTREY, ROBERT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$142,176"
Lymphoma,2011,NCI,5P01CA047741-18,8056,Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac,"CHAO, NELSON",DUKE UNIVERSITY,NC,"$948,884"
Lymphoma,2011,NCI,5P50CA121973-04,0005,Augmentation of Dendritic Cell-based Immunotherapy for Sezary Syndrome by T-reg D,"FALO, LOUIS",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$192,082"
Lymphoma,2011,NCI,5P50CA126752-05,0001,Immunotherapy for Hodgkin's Disease,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$236,989"
Lymphoma,2011,NCI,5P50CA126752-05,0002,Chimeric T Cell Antigens Targeting Kappa in B Cell Lymphoma,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$244,600"
Lymphoma,2011,NCI,5P50CA126752-05,0003,T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$245,499"
Lymphoma,2011,NCI,5P50CA126752-05,0004,Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy,"RONGFU, WANG",BAYLOR COLLEGE OF MEDICINE,TX,"$244,643"
Lymphoma,2011,NCI,5P50CA126752-05,0005,Targeting Malignant Stem Cells in CLL,"GOODELL, MARGARET",BAYLOR COLLEGE OF MEDICINE,TX,"$238,479"
Lymphoma,2011,NCI,5P50CA126752-05,0006,Research Development,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$152,964"
Lymphoma,2011,NCI,5P50CA126752-05,0007,Career Development,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$152,964"
Lymphoma,2011,NCI,5P50CA126752-05,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$66,675"
Lymphoma,2011,NCI,5P50CA126752-05,9002,Biostatistics and Data Management,"WEISS, HEIDI",BAYLOR COLLEGE OF MEDICINE,TX,"$118,443"
Lymphoma,2011,NCI,5P50CA126752-05,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$143,107"
Lymphoma,2011,NCI,5P50CA126752-05,9004,Tissue Resource,"GRESIK, VICTORIA",BAYLOR COLLEGE OF MEDICINE,TX,"$308,924"
Lymphoma,2011,NCI,5P50CA093683-09,0008,"SPORE Core 1: Administrative, Evaluation and Planning","MARASCO, WAYNE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$270,189"
Lymphoma,2011,NCI,5F31CA150546-02,,p53-independent function of Mdmx in tumorigenesis,"MELO, ALEXIA",VANDERBILT UNIVERSITY,TN,"$41,800"
Lymphoma,2011,NIA,1ZIAAG000166-10,,Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line,"FERRUCCI, LUIGI",NIH,,"$301,855"
Lymphoma,2011,NIA,1ZIAAG000451-03,,Role of Hyperplasia Suppressor Gene (HSG) in cell growth.,"FERRUCCI, LUIGI",NIH,,"$534,051"
Lymphoma,2011,NIA,1ZIAAG000768-08,,T cell development in the thymus and age-dependent thymic involution,"SEN, JYOTI",NIH,,"$258,762"
Lymphoma,2011,NIA,1ZIAAG000983-03,,Long-Term Consequences of Lymphoma and its Treatment,"EGAN, JOSEPHINE",NIH,,"$104,488"
Lymphoma,2011,NIAID,1ZIAAI000565-15,,Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B,"LENARDO, MICHAEL",NIH,,"$788,279"
Lymphoma,2011,NIAID,1ZIAAI000732-17,,"Clinical, Immunological and Genetic  Analyses of ALPS","RAO, VEMULKONDA",NIH,,"$434,343"
Lymphoma,2011,NIAID,1ZIAAI000858-12,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$485,745"
Lymphoma,2011,NIAID,1ZIAAI000913-10,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$451,033"
Lymphoma,2011,NIAID,1ZIAAI000978-06,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$371,010"
Lymphoma,2011,NIAID,1ZIAAI001070-04,,Targeted Killing of Herpesvirus-Infected Cells,"BERGER, EDWARD",NIH,,"$607,188"
Lymphoma,2011,NCI,5U01CA121947-05,6759,UCLA-USC Combined Los Angeles Core Site,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$538,004"
Lymphoma,2011,NCI,5U01CA121947-05,6761,UCSF Core Site,"KAPLAN, LAWRENCE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$538,004"
Lymphoma,2011,NIAID,1R56AI091767-01,,"HHV-8, angiogenesis and inflammation","CHANDRAN, BALA",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$386,250"
Lymphoma,2011,NIBIB,3R01EB012569-01A1S1,,Multi-functional Nanocarrier against Canine Lymphoma,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$26,827"
Lymphoma,2011,NEI,1ZIAEY000222-26,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$1,494,684"
Lymphoma,2011,NEI,1ZIAEY000375-11,,Primary Intraocular Lymphoma and Animal Models,"NUSSENBLATT, ROBERT",NIH,,"$49,167"
Lymphoma,2011,NCI,2P30CA086862-11,8601,Cancer Immunology and Immunotherapy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$52,490"
Lymphoma,2011,NCI,2P30CA086862-11,8684,Protocol Specific Research Support,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$55,020"
Lymphoma,2011,NCI,2P30CA016086-35,8689,Virology,"TRAUB, N",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$177,887"
Lymphoma,2011,NCI,2P30CA016086-35,8690,Virology,"TRAUB, N",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$187,746"
Lymphoma,2011,NINDS,1ZIANS003055-04,,Comprehensive multimodal analysis of patients with neuroimmunological diseases,"BIELEKOVA, BIBIANA",NIH,,"$527,319"
Lymphoma,2011,NHLBI,1ZIAHL005076-06,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$556,675"
Lymphoma,2011,NHLBI,1ZIAHL006070-02,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$556,675"
Lymphoma,2011,NCI,1ZIABC009265-29,,Analysis of the T Cell Repertoire,"HODES, RICHARD",NIH,,"$1,475,071"
Lymphoma,2011,RMAP,1ZIABC009265-29,,Analysis of the T Cell Repertoire,"HODES, RICHARD",NIH,,"$25,000"
Lymphoma,2011,NCI,1ZIABC009405-17,,Regulation of Lymphocyte Proliferation and Replicative Capacity,"HODES, RICHARD",NIH,,"$737,535"
Lymphoma,2011,NCI,1ZIABC010008-16,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$439,729"
Lymphoma,2011,NCI,1ZIABC010283-14,,DNA Repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,333,145"
Lymphoma,2011,NCI,1ZIABC010603-08,,Receptor-directed Therapy,"JANIK, JOHN",NIH,,"$497,717"
Lymphoma,2011,NCI,1ZIABC010621-08,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$708,140"
Lymphoma,2011,NCI,1ZIABC010715-06,,Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"WILSON, WYNDHAM",NIH,,"$122,100"
Lymphoma,2011,NCI,1ZIABC010716-06,,Phase I and II Study of BCL Family Inhibitors in Lymphoma,"WILSON, WYNDHAM",NIH,,"$244,201"
Lymphoma,2011,NCI,1ZIABC010717-06,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$122,100"
Lymphoma,2011,NCI,1ZIABC010719-06,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$122,100"
Lymphoma,2011,NCI,1ZIABC010728-06,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$122,100"
Lymphoma,2011,NCI,1ZIABC010885-04,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$919,323"
Lymphoma,2011,NCI,1ZIABC010888-04,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$1,313,319"
Lymphoma,2011,NCI,1ZIABC010925-04,,Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,"KONG, HEIDI",NIH,,"$101,371"
Lymphoma,2011,NCI,1ZIABC011006-04,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$971,205"
Lymphoma,2011,NCI,1ZIABC011007-04,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$971,205"
Lymphoma,2011,NCI,1ZIABC011008-04,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$971,205"
Lymphoma,2011,NCI,1ZIABC011064-04,,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"MOCK, BEVERLY",NIH,,"$329,797"
Lymphoma,2011,NCI,1ZIABC011065-04,,Preclinical Testing of HDAC and mTOR Inhibitors,"MOCK, BEVERLY",NIH,,"$329,797"
Lymphoma,2011,NCI,1ZIABC011070-04,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$574,046"
Lymphoma,2011,NCI,1ZIABC011192-03,,The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,"VAN DYKE, TERRY",NIH,,"$298,174"
Lymphoma,2011,NCI,1ZIABC011338-02,,Functional Analysis of the REL Transcription Factors in B-Cells,"LEWIS, BRIAN",NIH,,"$295,053"
Lymphoma,2011,NCI,1ZIABC011354-02,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$122,100"
Lymphoma,2011,NCI,1ZIABC011374-01,,Allotransplant for DOCK8 deficiency,"HICKSTEIN, DENNIS",NIH,,"$213,623"
Lymphoma,2011,NCI,1ZIABC011413-01,,Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$156,999"
Lymphoma,2011,NCI,1ZIABC011417-01,,New Chimeric Antigen Receptors for Treating Hematologic Malignancies,"KOCHENDERFER, JAMES",NIH,,"$156,999"
Lymphoma,2011,NCI,1ZIACP004410-35,,Family Studies,"TUCKER, MARGARET",NIH,,"$3,434,905"
Lymphoma,2011,NCI,1ZIACP005782-17,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$444,920"
Lymphoma,2011,NCI,1ZIACP010125-16,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,972,751"
Lymphoma,2011,NCI,1ZIACP010131-16,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON, AMY",NIH,,"$2,973,851"
Lymphoma,2011,NCI,1ZIACP010150-12,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$911,869"
Lymphoma,2011,NCI,1ZIACP010170-11,,Multidisciplinary Studies of Hematopoietic Malignancies,"MORTON, LINDSAY",NIH,,"$1,371,718"
Lymphoma,2011,NCI,1ZIACP010176-11,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$1,656,987"
Lymphoma,2011,NCI,1ZIACP010212-02,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$315,408"
Lymphoma,2011,NCI,1ZIACP010214-02,,Microbes and Human Malignancies,"GOEDERT, JAMES",NIH,,"$710,295"
Lymphoma,2011,NHGRI,1ZIAHG000123-14,,Genetic and Biochemical Approaches to Tyrosine Kinase Function,"SCHWARTZBERG, PAMELA",NIH,,"$1,941,623"
Lymphoma,2011,NCI,1ZIASC000550-31,,Lymphoma Disease Discovery and Defintion,"JAFFE, ELAINE",NIH,,"$1,148,092"
Lymphoma,2011,NCI,1ZIASC004002-42,,IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"WALDMANN, THOMAS",NIH,,"$1,751,169"
Lymphoma,2011,NCI,1ZIASC006741-19,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$366,301"
Lymphoma,2011,NCI,1ZIASC010356-12,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$500,541"
Lymphoma,2011,NCI,1ZIASC010357-12,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$969,771"
Lymphoma,2011,NCI,1ZICBC010548-09,,Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,"FIGG, WILLIAM",NIH,,"$595,171"
Lymphoma,2011,NCI,1ZICBC010953-04,,Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"SIMPSON, ROBERT",NIH,,"$1,283,936"
Lymphoma,2011,NCI,1ZICBC011029-04,,Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,"HAKIM, FRANCES",NIH,,"$248,041"
Lymphoma,2011,NCI,1ZICBC011079-04,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$1,844,045"
Lymphoma,2011,NCI,1ZICBC011093-04,,FLow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$202,141"
Lymphoma,2011,NCI,1ZIDBC010990-04,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$7,587,024"
Lymphoma,2011,NCI,1ZIEBC011241-03,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$574,046"
Lymphoma,2011,NCI,1ZIGBC010856-05,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$17,605,202"
Lymphoma,2011,NIDDK,261201100019C-2-0-3,,FT11 NIDDK (WA03),"ESTEP, JAMES",BATTELLE CENTERS/PUB HLTH RES & EVALUATN,OH,"$240,000"
Lymphoma,2011,NCRR,5M01RR000188-47,6618,ADMINISTRATION OF TGF-B RESISTANT LMP2A-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO P,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$14,643"
Lymphoma,2011,NCRR,5M01RR000188-47,6656,PHASE I STUDY OF THE ADMINISTRATION OF PERIPHERAL ACTIVATED T-CELLS OR EBV,"RAMOS, CARLOS",BAYLOR COLLEGE OF MEDICINE,TX,"$5,144"
Lymphoma,2011,NCRR,5M01RR000188-47,6700,CLINICAL TRIAL:  THE ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECI,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,$395
Lymphoma,2011,NCRR,5M01RR000188-47,6701,CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$1,187"
Lymphoma,2011,NCRR,5M01RR000188-47,6706,CLINICAL TRIAL:  NEOMYCIN RESISTANCE LMP2A SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$41,950"
Lymphoma,2011,NCRR,2P51RR000165-51,7191,A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES,"VILLINGER, FRANCOIS",EMORY UNIVERSITY,GA,"$74,294"
Lymphoma,2011,NCRR,5P51RR000166-50,7271,"A PRIMATE MODEL OF GUT, IMMUNE, AND CNS RESPONSE TO CHILDHOOD VACCINES","SACKETT, GENE",UNIVERSITY OF WASHINGTON,WA,"$154,384"
Lymphoma,2011,OD,5P51RR000166-50,7271,"A PRIMATE MODEL OF GUT, IMMUNE, AND CNS RESPONSE TO CHILDHOOD VACCINES","SACKETT, GENE",UNIVERSITY OF WASHINGTON,WA,"$2,250"
Lymphoma,2011,NCRR,5P51RR000163-52,7398,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$238,367"
Lymphoma,2011,NIA,5P51RR000163-52,7398,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$5,196"
Lymphoma,2011,NCRR,5P51RR000168-50,7573,PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTION,"WANG, FREDERICK",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$68,415"
Lymphoma,2011,NCRR,5P51RR000168-50,7689,A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES,"WANG, FREDERICK",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$68,415"
Lymphoma,2011,NCRR,1P20RR024219-01A2,7956,CENTER FOR CANCER BIOLOGY RESEARCH,"MISKIMINS, W",SANFORD RESEARCH/USD,SD,"$2,251,826"
Lymphoma,2011,NCRR,5P20RR018724-09,8087,LSUHSC COBRE:  DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY,"TIBBETTS, SCOTT",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$61,170"
Lymphoma,2011,NCRR,5P20RR018789-09,8579,4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT,"MILLS, KEVIN",MAINE MEDICAL CENTER,ME,"$150,866"
Lymphoma,2011,NCRR,5P20RR018759-09,8747,MECHANISM OF ABERRANT DNA METHYLATION IN MOUSE LYMPHOMAGENESIS,"OPAVSKY, RENE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$271,936"
Lymphoma,2011,NCRR,5P20RR021970-07,8761,TUMOR MICROENVIRONMENT AND B CELL LYMPHOMAS,"YOON, SUN-OK",LOUISIANA STATE UNIV HSC NEW ORLEANS,LA,"$105,968"
Lymphoma,2011,NCRR,5P41RR000862-38,5740,"STRUCTURE FUNCTION STUDY OF A NOVEL TUMOR SUPPRESSOR, EPHA","WENDEL, HANS-GUIDO",ROCKEFELLER UNIVERSITY,NY,"$13,036"
Lymphoma,2011,NCRR,5P41RR015301-09,5874,STRUCTURAL DETERMINATION OF PF-8 IN-COMPLEX WITH DNA,"HOGLE, JAMES",CORNELL UNIVERSITY ITHACA,NY,"$14,617"
Lymphoma,2011,NCRR,5P41RR002305-27,6163,REDOX IMAGING OF HUMAN LYMPHOMA,"LI, LIN",UNIVERSITY OF PENNSYLVANIA,PA,"$7,688"
Lymphoma,2011,NCRR,5P41RR001614-29,7910,POSTTRANSLATIONAL MODIFICATION OF RASGRP1 PROTEIN IN T LYMPHOCYTES,"ROOSE, JEROEN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,$630
